Voyager Acquisition Corp/cayman Islands 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
Voyager Acquisition Corp. reports Q1 2026 financial results while progressing toward its business combination with Veraxa Biotech AG.
NASDAQ
Voyager Acquisition Corp. reported increased net income for Q3 2025 and the nine months ended September 30, 2025, while progressing its business combination with Veraxa Biotech AG.
NASDAQ
Voyager Acquisition Corp. reported a net income of $2.49 million for Q2 2025, driven by trust account interest, and announced a definitive business combination agreement with Veraxa Biotech AG.
NASDAQ
Voyager Acquisition Corp. reports net income for Q1 2025 and announces a business combination agreement with Veraxa Biotech AG.
NASDAQ
10-Q: Voyager Acquisition Corp. Reports Net Income of $1.2 Million in Q3 2024 Following Successful IPO
Voyager Acquisition Corp. reported a net income of $1.2 million for the nine months ended September 30, 2024, primarily driven by interest and unrealized gains from investments held in trust after its initial public offering.
NASDAQ
Voyager Acquisition Corp. reports a net loss of $102,848 for the six months ended June 30, 2024, while also completing its initial public offering in August.